PN summer web series kicks off in July! Learn more

December 2022

Understanding the Connection Between Polyneuropathy and hATTR Amyloidosis

In October, FPN and Alnylam Pharmaceuticals hosted an educational webinar about hereditary ATTR (hATTR) amyloidosis and its connection with polyneuropathy. Check out the program summary for more information and additional resources by clicking below.

Click here.

Neurologic Health & Environmental Factors

A recent study from the Cleveland Clinic has shown that neurologic health has worsened due to climate change and airborne pollution. Exposure to temperature extremes and fine particulate matter and nitrates has been directly tied to risk of neurological conditions.

Read more.

Year-End Giving from Your IRA

It’s that giving time of year! As you are planning your year-end donations, don’t forget that you can make a gift directly from your IRA to your charity of choice, tax-free!

Learn more.

Acupuncture May Alleviate Neuropathy Symptoms

Clinical studies have shown that acupuncture may relieve symptoms for patients with peripheral neuropathy. A recent clinical study analyzed the effects of two treatment protocols in patients with diabetic neuropathy.

Read the study results.

FPN Webinar: The Thrive State

On December 7, FPN hosted an educational program on The Thrive State, featuring guest speaker Dr. Kien Vuu, sponsored by LivOn Labs.

After studying human performance and the longest-lived populations on the planet, Dr. Vuu has discovered the one trait that activates the biology of health, longevity, and human performance. The Thrive State is an energetic field – a state of being – that each of us can learn to harness to activate more health, resilience, and hope into our lives. The Thrive State is a holistic approach for patients with peripheral neuropathy (PN) or any chronic illness. That even during times of uncertainty and hardship, we can access the Thrive State to unlock the resources within ourselves to heal and improve our health, spirit, and lives. 

View recording.

Spinal Cord Stimulators for Patients with Chronic Pain

A retrospective study published in MEDPAGE TODAY finds no reduction in opioid use for patients who use permanent spinal cord stimulators (SCS) versus conventional medical management.

Read more.

There is Still Time

Don’t let time run out on 2022… there is still time to support FPN with a year-end donation. Please consider making a gift now to support our investment in research and help create a better quality of life for PN patients and their families.  

Thank you for your support and Happy Holidays!

The Foundation for Peripheral Neuropathy provides education and support today as we walk toward a cure for tomorrow.

Support us in advancing a cure!

FPN is a non-profit organization that is solely funded by our readers.

Donate Now!